According to filings with the U.S. Securities and Exchange Commission, Kubera Health has raised $6.5 Million in new Seed funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

Investors in the company’s current round of funding include: Upfront Ventures, Company Ventures, Dria Ventures, and SemperVirens

About Kubera Health
Upfront Ventures is proud to be an early investor and long-term partner to tech founders and startups. Founded in 1996 in Los Angeles with investing professionals based in LA and San Francisco, Upfront has backed teams across all technology sectors including hard tech, healthcare, gaming, fintech, SaaS, and developer tools. We invest about half of our capital in the fast-growing Southern California ecosystem, with the balance across the country as well as investments in Europe.

To learn more, visit https://www.kuberahealth.com/
Linkedin: https://www.linkedin.com/company/kubera-health/

Contact:
Roja Garimella, Chief Executive Officer
https://www.linkedin.com/in/rojagarimella/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.